GadgetsIn Vivo Gene Therapy and CRISPR Cures for Lethal Rare Diseases Move from Lab to Standard Care
In 2026, in vivo gene therapies and CRISPR cures for rare diseases are becoming standard care, highlighted by vision res...
Read More →Gadgets
GadgetsAI in Drug Discovery 2026: FDA Qualifies First AI Tool for Clinical Trials as Industry Shifts to Multimodal Models
The FDA has qualified its first AI tool for clinical trials in 2026, validating the use of multimodal models and digital...
Read More →
GadgetsNext-Generation CAR-T Cell Therapies Break Into Solid Tumors with KIR-CAR and Armored Cells
Next-generation CAR-T therapies, including KIR-CAR and armored cells secreting IL-12, are breaking into solid tumors by ...
Read More →
GadgetsThe Gut Microbiome and Autoimmune Diseases: Harnessing Regulatory T Cells for Immune Reset
Building on the Nobel Prize-winning discovery of Regulatory T Cells, 2026 research focuses on harnessing the gut microbi...
Read More →
GadgetsSenolytics Enter Advanced Clinical Trials: Targeting Cellular Senescence for Longevity and Alzheimer's
Senolytic drugs like dasatinib and quercetin are entering advanced clinical trials in 2026, targeting senescent "zombie ...
Read More →
GadgetsNeuralink's Brain-Computer Interface Achieves FDA Breakthrough for Speech Restoration in 2026
Neuralink has received FDA Breakthrough Device Designation for its speech restoration BCI technology, aiming to translat...
Read More →
GadgetsGLP-1 Medications in 2026: Medicare Coverage Expansion and Beyond Weight Loss
GLP-1 medications in 2026 are transforming from weight-loss drugs to essential cardiovascular and renal therapies. With ...
Read More →
GadgetsModerna and Merck's mRNA Cancer Vaccine Shows Sustained 5-Year Survival Benefit in Melanoma
Moderna and Merck's 5-year follow-up data for the personalized mRNA cancer vaccine intismeran autogene shows a sustained...
Read More →
GadgetsAlzheimer's Disease Drug Pipeline 2026: Subcutaneous Lecanemab and Revolutionary Blood Tests
The 2026 Alzheimer's pipeline features 192 clinical trials, highlighted by the FDA approval of subcutaneous Leqembi and ...
Read More →
GadgetsCRISPR Clinical Trials 2026: From Sickle Cell Cures to Next-Generation Base Editing
The CRISPR clinical landscape in 2026 has expanded to over 250 active trials, moving beyond sickle cell disease into in ...
Read More →